510(k) K173833

CRP Vario by SENTINEL CH. SpA — Product Code NQD

K173833 is an FDA 510(k) premarket notification submitted by SENTINEL CH. SpA for the device "CRP Vario". The FDA issued a decision of Substantially Equivalent on September 27, 2018. The device falls under product code NQD (Cardiac C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. SENTINEL CH. SpA has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 27, 2018
Date Received
December 18, 2017
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.